ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL3362 |
|
948557-43-5 |
Tie2 kinase inhibitor 1 98+% |
C26H21N3O2S | |
HL2024 |
|
1429-30-7 |
Petunidin Chloride 98+% |
C16H13ClO7 | |
CL1457A |
|
1256589-74-8 |
Alectinib Hydrochloride (Synonyms: CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride;Alectinib HCl) 99+% |
C30H35ClN4O2 | |
CL3234 |
|
1188379-43-2 |
Insulin Icodec 98+% |
C280H435N71O87S6 | |
CL3227A |
|
2119669-71-3 |
Asciminib hydrochloride (Synonyms: ABL001 hydrochloride) 98+% |
C20H19Cl2F2N5O3 | |
CL3227 |
|
1492952-76-7 |
Asciminib (Synonyms: ABL001) 98+% |
C20H18ClF2N5O3 | |
CL3192 |
|
1341200-45-0 |
Dubermatinib (Synonyms: TP-0903) 98+% |
C24H30ClN7O2S | |
CL1894A |
|
1025687-58-4 |
Fostamatinib Disodium;R788 Disodium 98+% |
C23H24FN6Na2O9P | |
CLP1144 |
|
1401708-83-5 |
Dihexa (Synonyms: PNB-0408; N-hexanoic-Try-Ile-(6)-amino hexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2) 98+% |
C27H44N4O5 | |
CL3145 |
|
257933-82-7 |
Pelitinib (Synonyms: EKB-569; WAY-EKB 569) 98+% |
C24H23ClFN5O2 | |
CL3126 |
|
1707289-21-1 |
Fisogatinib (Synonyms: BLU-554) 98+% |
C24H24Cl2N4O4 | |
CL3117 |
|
1513857-77-6 |
Pemigatinib (Synonyms: INCB054828) 99+% |
C24H27F2N5O4 | |
CL1632A |
|
439081-18-2 |
(E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; (S)-阿法替尼) 98+% |
C24H25ClFN5O3 | |
CL3105 |
|
1303420-67-8 |
PLX5622 98+% |
C21H19F2N5O | |
CL3084 |
|
761439-42-3 |
NVP-TAE 684 | TAE 684 98+% |
C30H40ClN7O3S | |
CL3074 |
|
928037-13-2 |
Golvatinib | E-7050 98+% |
C33H37F2N7O4 | |
CL3050 |
|
133550-30-8 |
AG490 (Synonyms: Tyrphostin AG490; Tyrphostin B42) 98+% |
C17H14N2O3 | |
CL2211A |
|
1421373-66-1 |
AZD-9291 mesylate | Osimertinib mesylate | Mereletinib mesylate 98+% |
C29H37N7O5S | |
CLA1682 |
|
1826843-81-5 |
Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) 98+% |
— | |
CL2990 |
|
670220-88-9 |
Crenolanib | CP-868596 | ARO 002 98+% |
C26H29N5O2 | |